Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response.
about
Immunometabolism in TuberculosisThe dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunityExtrapulmonary tissue responses in cynomolgus macaques (Macaca fascicularis) infected with highly pathogenic avian influenza A (H5N1) virus.Intracellular pathogen Leishmania donovani activates hypoxia inducible factor-1 by dual mechanism for survival advantage within macrophage.Hypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious DiseasesIRF-5-Mediated Inflammation Limits CD8+ T Cell Expansion by Inducing HIF-1α and Impairing Dendritic Cell Functions during Leishmania InfectionOncolytic targeting of renal cell carcinoma via encephalomyocarditis virusInverse Correlation between IL-10 and HIF-1α in Macrophages Infected with Histoplasma capsulatumBC-box protein domain-related mechanism for VHL protein degradation.IFN-alpha induces transcription of hypoxia-inducible factor-1alpha to inhibit proliferation of human endothelial cells.Regulation of HIV-1 transcription at 3% versus 21% oxygen concentrationInterdependence of hypoxic and innate immune responsesOncolytic virotherapy for renal cell carcinoma: a novel treatment paradigm?Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53.The oncolytic activity of Newcastle disease virus in clear cell renal carcinoma cells in normoxic and hypoxic conditions: the interplay between von Hippel-Lindau and interferon-β signaling.Down-regulation of HIF-1alpha by oncolytic reovirus infection independently of VHL and p53.Going (Reo)Viral: Factors Promoting Successful Reoviral Oncolytic Infection
P2860
Q27021247-73AC18A0-95FD-4EB8-BADD-6122EEF011FDQ28384138-27E207A5-D927-4DC6-BF45-95F993B89592Q30387752-BD63DBAC-91D1-4AB0-807C-3D5C1E00C8D7Q34305465-F2029F21-DA6F-4F52-8FC0-0F53DE51374CQ34726144-43D44500-E544-4B86-923D-66F5E1EF9C36Q35653927-7B8043D8-C4DF-41B0-A42C-D3A964868D43Q36039304-A7770250-EA57-4789-9347-403AD597857CQ37072151-1BCD3CDB-8413-4F4E-8CC0-F1415B04AF14Q37318235-FF6AC0F7-BBB9-4303-B1B3-FD762375DF5EQ37331575-1ABA11AC-01E5-42D1-AFE6-AD7FA0032944Q37423506-EF96C604-F997-4AE1-B014-8593258B8768Q37586121-0585691F-8A4B-46B3-85EF-FA2E13A01EB8Q38008023-85E393E1-702E-4D9F-AC2A-BBE94849F50FQ38728290-1C96F2CB-53BF-4CDE-8BB6-87DB103C57BEQ39179082-5066AD24-574A-4CDC-9EDA-49B9BC5C3F95Q39751672-CCAE7648-B3E3-4868-BCE4-78CFC7774577Q56986466-C709C1AC-3740-4CC8-B8B1-D120B5BAF79B
P2860
Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Loss of VHL confers hypoxia-in ...... of HIF in antiviral response.
@ast
Loss of VHL confers hypoxia-in ...... of HIF in antiviral response.
@en
type
label
Loss of VHL confers hypoxia-in ...... of HIF in antiviral response.
@ast
Loss of VHL confers hypoxia-in ...... of HIF in antiviral response.
@en
prefLabel
Loss of VHL confers hypoxia-in ...... of HIF in antiviral response.
@ast
Loss of VHL confers hypoxia-in ...... of HIF in antiviral response.
@en
P2093
P2860
P356
P1433
P1476
Loss of VHL confers hypoxia-in ...... of HIF in antiviral response.
@en
P2093
Ian R Watson
Irene I L Hwang
Michael Ohh
Sandy D Der
P2860
P304
10712-10723
P356
10.1128/JVI.01014-06
P407
P577
2006-08-23T00:00:00Z